Walleye Capital’s Peak Bio, Inc. Warrant PKBOW Stock Holding History

Walleye Capital’s Portfolio PKBOW Stock Details PKBOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-12,249	Closed	-$2.48K	–	4693
2022 Q4	$2.48K	Buy	12,249 +1,647	+16%	+$309	﹤0.01%	2957
2022 Q3	$1K	Hold	10,602	–	–	﹤0.01%	3166
2022 Q2	$2K	Hold	10,602	–	–	﹤0.01%	2279
2022 Q1	$3K	Sell	10,602 -398	-4%	-$170	﹤0.01%	2237
2021 Q4	$8K	Buy	+11,000	New	+$8.06K	﹤0.01%	2054

Other funds holding PKBOW

EFI

EHP Funds Inc Toronto, Canada $43.6M AUM 69.08% 1-Year Est. Return

CCM

Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Walleye Capital's PKBOW Position: Q1 2023 in Review

Walleye Capital sold out of Peak Bio, Inc. Warrant (PKBOW) in Q1 2023, closing a stake of 12,249 shares — an estimated $2.48K sold.

Walleye Capital first reported a position in PKBOW in Q4 2021 and held it in 5 quarters. The position peaked at $8K in Q4 2021. 5 funds tracked by Wall St. Rank hold PKBOW as of Q1 2023.

Walleye Capital reported no remaining Peak Bio, Inc. Warrant position as of Q1 2023 after selling out during the quarter.
Walleye Capital sold 12,249 Peak Bio, Inc. Warrant shares in Q1 2023, an estimated $2.48K.
Walleye Capital first reported a position in Peak Bio, Inc. Warrant in Q4 2021 and held it in 5 quarters.
Walleye Capital's Peak Bio, Inc. Warrant position peaked at $8K in Q4 2021.
5 funds tracked by Wall St. Rank held Peak Bio, Inc. Warrant as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.